20
Cerbios Pharma Sa, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Cerbios offers CDMO services for HPAPIs, ADCs & recombinant proteins & is active in the field of generic APIs & probiotics (SF68®).
One of their notable products is CALCIPOTRIENE ANHYDROUS, with a corresponding US DMF Number 23103.
Remarkably, this DMF maintains an Active status since its submission on September 09, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 05, 2015, and payment made on June 26, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II